3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer -

Survival rate with melanoma has improved

CancerApr 07, 07

The overall survival of people diagnosed with melanoma, the most serious type of skin cancer, has improved over the past 25 years or so, German researchers report.

They note in their report in the medical journal Cancer that melanoma is quite curable if it’s caught early; however, the improvement in survival they have observed may not be entirely due to early diagnosis.

Dr. Claus Garbe and colleagues from Eberhard-Karis-University in Tuebingen analyzed the survival of 4791 patients diagnosed with invasive melanoma in southern Germany between 1976 and 2001, in order to assess factors associated with better survival rates.

The proportion of patients who survived for 10 years, overall, was 88.6% among patients diagnosed in 1990-2001, significantly better than the 80.0% of those diagnosed in 1976-1989.

One factor that affects the deadliness of the tumor is its thickness. The researchers found that the average tumor thickness decreased from 1.07 mm in the period 1976-1989 to 0.75 mm in 1990-2001.

The investigators’ analysis showed that tumor thickness, ulceration, age, gender, anatomical site, and period of primary diagnosis independently predicted overall survival.

“Interestingly, we found that the survival of patients diagnosed since 1990 seemed to have improved beyond the effects of early diagnosis,” Garbe’s team comments.

“This could be explained by changes in unmeasured biologic features of melanoma, or by improvements in the management of this disease,” they suggest.

SOURCE: Cancer, March 15, 2007.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site